(3S)-1-[(R)-2-羟基-1-苯乙基]-3-甲基-2-哌啶酮的合成(英文)

被引:0
作者
Xiaozhong WANG [1 ]
Xia WANG [1 ]
Yingqi CHEN [1 ]
Liyan DAI [1 ]
Xingcong LI [2 ]
机构
[1] College of Chemical and Biological Engineering, Zhejiang University
[2] National Centers for Natural Products Research, Research Institute of Pharmaceutical Sciences, The University of
关键词
哌啶酮; 生物碱; 不对称合成; D-苯甘氨醇; 醇羟基保护基;
D O I
暂无
中图分类号
O621.3 [有机合成化学];
学科分类号
摘要
目的:探索合成(3S)-1-[(R)-2-羟基-1-苯乙基]-3-甲基-2-哌啶酮的新方法。创新点:以常规化工原料D-苯苷氨醇为主要原料,在比较温和的条件下合成重要的药物中间体(3S)-1-[(R)-2-羟基-1-苯乙基]-3-甲基-2-哌啶酮及其同系物。该方法中的甲基化步骤较常规甲基化步骤减少1当量s-Bu Li的用量,更环保和安全。方法:利用D-苯苷氨醇的空间位阻作用,在六元环内酰胺中引入具有特定光学纯度的手性甲基。在甲基化过程中,用叔丁基二甲基氯硅烷对羟基进行保护,以减少仲丁基锂的用量。结论:以工业易得的δ-戊内酯及D-苯苷氨醇为初始原料,探索合成3-甲基-2-哌啶酮类物质的新方法。新方法中对仲丁基锂的消耗量与常规方法有所不同。当羟基受保护时,甲基化1当量六元环内酰胺(化合物7)消耗1.5当量而非2.5当量仲丁基锂,甲基化产物脱掉醇羟基保护基,得到(3S)-1-[(R)-2-羟基-1-苯乙基]-3-甲基-2-哌啶酮(化合物1)及其非对映异构体(3R)-1-[(R)-2-羟基-1-苯乙基]-3-甲基-2-哌啶酮(化合物8),二者摩尔比为1:2.5。通过重结晶或柱层析的方法可对二者进行完全分离。
引用
收藏
页码:163 / 170
页数:8
相关论文
共 12 条
  • [1] DIASTEREOSELECTIVE APPROACH TO cis-4-METHYL/THIOL-PIPECOLIC ESTERS BASED ON RCM REACTION AND CONJUGATE MICHAEL ADDITION
    Zarate, Araceli
    Orea, Laura
    Juarez, Jorge R.
    Castro, Alejandro
    Mendoza, Angel
    Gnecco, Dino
    Teran, Joel L.
    [J]. SYNTHETIC COMMUNICATIONS, 2014, 44 (19) : 2838 - 2847
  • [2] Design, synthesis and biological evaluation of novel aminomethyl-piperidones based DPP-IV inhibitors[J] . Pradip Jadav,Rajesh Bahekar,Shailesh R. Shah,Dipam Patel,Amit Joharapurkar,Mukul Jain,Kalapatapu V.V.M. Sairam,Praveen Kumar Singh. Bioorganic & Medicinal Chemistry Letters . 2014
  • [3] Four New Alkaloids from the Fermentation Broth of Armillaria mellea
    Wang, Yun-Chao
    Zhang, Yu-Wei
    Zheng, Li-Hua
    Bao, Yong-Li
    Wu, Yin
    Yu, Chun-Lei
    Huang, Yan-Xin
    Sun, Lu-Guo
    Zhang, Yu
    Jia, Xiu-Juan
    Li, Yu-Xin
    [J]. HELVETICA CHIMICA ACTA, 2013, 96 (02) : 330 - 337
  • [4] A practical procedure for the removal of the phenylethanol moiety from phenylglycinol-derived lactams
    Semak, Vladislav
    Escolano, Carmen
    Arroniz, Carlos
    Bosch, Joan
    Amat, Mercedes
    [J]. TETRAHEDRON-ASYMMETRY, 2010, 21 (20) : 2542 - 2549
  • [5] The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4- bis (benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5- bis (benzylidene)-1-methyl-4-piperidones[J] . Hari N. Pati,Umashankar Das,Swagatika Das,Brian Bandy,Erik De Clercq,Jan Balzarini,Masami Kawase,Hiroshi Sakagami,J. Wilson Quail,James P. Stables,Jonathan R. Dimmock. European Journal of Medicinal Chemistry . 2008 (1)
  • [6] Efficient preparation of (1′ R )-(?)-1-(2′-hydroxy-1′-phenylethyl)piperidin-2-one: synthesis of (2′ S ,3 R )-(+)-stenusine[J] . Alejandro Castro -C.,Jorge Juárez -P.,Dino Gnecco,Joel L. Terán,Alberto Galindo,Sylvain Bernès,Raúl G. Enríquez. Tetrahedron: Asymmetry . 2005 (5)
  • [7] Preparation of oxime dual NK1/NK2 antagonists with reduced NK3 affinity
    Reichard, GA
    Grice, CA
    Shih, NY
    Spitler, J
    Majmundar, S
    Wang, SD
    Paliwal, S
    Anthes, JC
    Piwinski, JJ
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (17) : 2355 - 2358
  • [8] Asymmetric synthesis of 3-substituted pyrrolidones via α-alkylation of a chiral non-racemic γ-lactam
    Baussanne, I
    Travers, C
    Royer, J
    [J]. TETRAHEDRON-ASYMMETRY, 1998, 9 (05) : 797 - 804
  • [9] Diastereoselective alkylation of homochiral 1,2,3,4-tetrahydroisoquinolin-3-one. A potential route to enantiomerically pure 4-substituted tetrahydroisoquinolines[J] . Nicolas Philippe,Vincent Levacher,Georges Dupas,Jack Duflos,Guy Quéguiner,Jean Bourguignon. Tetrahedron: Asymmetry . 1996 (2)
  • [10] Asymmetric synthesis. XXXV 1 . Synthesis of 2-methyl 5-substituted substituted piperidines from chiral non-racemic lactams[J] . Teresa Varea,Monique Dufour,Laurent Micouin,Claude Riche,Angèle Chiaroni,Jean-Charles Quirion,Henri-Philippe Husson. Tetrahedron Letters . 1995 (7)